Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection

Completed · Early Phase 1

Conditions studied: Covid19

In brief

Prospective, cross-sectional study evaluating the effect of commercially available mouthwashes on expelled/exhaled SARS-CoV-2 viral load using face mask sampling.

Key facts

Study ID

NCT04931004

Run by

Rutgers, The State University of New Jersey

People needed

34

Starts

2021-07-21

Expected to finish

2022-12-31

Last updated by the study team

2026-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18
• Able to provide consent
• Polymerase chain reaction (PCR)-confirmed SARS-CoV-2 within previous 48 hours.

You may not qualify if…

• Clinical contraindication or poor feasibility to complete study procedures
• Unwilling or unable to produce saliva or face mask samples
• Unable to produce at least 500 microliters of saliva.
• Eaten within past 30 minutes
• Known allergy to mouthwash products

Where it is running

• University Hospital — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.